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Hereditary fructose intolerance (HFI),1 an autosomal recessive trait, characterized by diarrhea, vomiting, and hypoglycemia after ingestion of fructose, is associated with a deficiency of fructose-bisphosphate aldolase (EC 2.1.2.13) (1, 2). The aldolase is present in the form of three genetically distinct isoenzymes: muscle type A, liver type B, and brain type C (3). Only aldolase B catalyzes metabolism of fructose-1-phosphate (F1P). A deficiency of aldolase B was demonstrated in liver (2), intestine (4) , and kidney (5) of patients with HFI. The biochemical basis of the disorder was a mutant enzyme with altered characteristics (6) (7) (8) (9) . The homozygosity can be diagnosed by determining the aldolase activity on two substrates: F1P and fructose-1,6-bisphosphate (FBP). Spectrophotometry involving NADH-dependent glycerophosphate dehydrogenase (EC 1.1.1.8) (1, 10, 11), however, requires a relatively large quantity of tissue sample and is not always specific. For some uncertain cases other diagnostic procedures (8, 12, 13) were necessary to establish the diagnosis.
Our purpose was to develop a more sensitive and specific method for aldolase B assay, to facilitate diagnosis of the disorder. The simple radioisotopic method described here is very specific and much more sensitive than the former methods. The activity of aldolase B and its kinetic characteristics were determined by use of the method for samples of liver and intestine from patients with HFI.
Metabolic Unit, Children's Hospital, University of Munich, Lindwurrnstr. 4 (250 MCi), and 0.1 U of fructokinase, all in a total volume of 3 mL. After a 1-h incubation at 37 #{176}C the reaction was stopped by heating at 95 #{176}C for 3 mm, and the mixture was diluted to 10 mL with distilled water. The product was purified on a 0.9 x 15 cm diethylaminoethyl (DEAE).-.cellulose column with a gradient of 0.01 to 0.3 molt L triethanolamine buffer, pH 7.4. The yield was approximately 30%. After a 1-h incubation the reaction was terminated by heating at 95 #{176}C for 3 mm. The product, glyceraldehyde, was separated from F1P and dihydroxyacetone phosphate on a mini DEAE-cellulose column as described previously for galactokinase assay (15) and pyridoxal-5'-PO4 assay (16) except that the glyceraldehyde was eluted with water instead of dilute HC1. We examined the reaction of nonspecific phosphatase, which may contaminate the water fractions with fructose, by looking for fructose in these fractions, but could detect none. Blanks consisted of extracts in which the protein had been denatured before being added to the reaction mixture.
Materials and Methods

Preparation of Tissue Extracts
Radioisotopic
Protein was determined with a modification (17) of the procedure of Lowry et al. (18); 1 pg of protein could be determined.
The aldolase activity was expressed as nanomoles of glyceraldehyde formed per minute per milligram of protein.
Spectrophotometry.
This was according to the procedure of Gitzelmann (10).
mal reference interval. With the radioisotopic method, however, we found both the aldolase activity and Km values to be normal, and indeed both cases were eventually found to be clinically normal. On the other hand, HFI liver 2, for which the spectrophotometric method at first yielded a relatively high value for the aldolase activity (3 units) as well as a low activity ratio, was confirmed to be HFI by the enzyme assay with the radioisotopic method and by the clinical symptoms. Repetition of the assay with the spectrophotometric procedure produced quite different values (Table 1). Study of the kinetic characteristics shows that the residual activities in liver and intestine were ascribable to the mutant enzyme, for which the relationship between reaction velocity and substrate concentration differed from the normal (Table 1 and Figure 3) . Lineweaver-Burk plots Results Figures 1 and 2 illustrate the dependency of the aldolase  reaction on the duration of incubation and for Km values in the patients gave nonlinear hyperbolic curves, indicating a substrate activation effect (19), in contrast to the case of the normal (apparent Km 1.5 mmol/L). As shown in Figure 4 , therefore, the difference in enzyme activity between the normal subjects and the homozygotes for HF! was more pronounced when a lower concentration of F1P was used in the assay. When a high concentration of F1P such as 10 mmolJL was used, the values for normal livers were as high as 60 U/g of protein, and in HF! as high as 15 U/g.
Discussion
The present procedure is relatively simple and reproducible. Radioactive fructose-i-phosphate is easily prepared from inexpensive [U-'4Cjfructose. Furthermore, relatively small amounts of biopsy sample are required as compared with the spectrophotometric method. Multiple assays can be performed when the partly automated mini-column chromatographic procedure (15, 16) is applied. In some cases the (6) (7) (8) (9) . We also have observed an extremely low affinity to F1P in the patients with HFI under normal physiological conditions. In addition, aldolase B in HFI yielded a hyperbolic Lineweaver-Burk plot for F1P, suggesting a substrateactivation effect (19). As seen in Figures  3 and 4 , the difference in the enzyme activity between normal and HF! is more distinctive with lower concentrations of F1P. Therefore we recommend use of a F1P concentration of approximately 0.5 mmol/L in the assay if only single measurements are to be done. In some obscure cases, such as a few cases shown in Table 1 As was true for leukocytes, there was no significant difference in the fibroblast enzyme activity between the genotypes. However, the activity ratio (FBP/ F1P) was much lower (-3) than that of aldolase A or C (-'-10), being in the range of that for fetal liver or hepatoma cells(20-23). These observations led us to speculate that fast-growing and young populations of cells may contain proportionately more aldolase A, and aldolase B may be produced as they mature. It would be interesting to investigate this enzyme in cultured fibroblasts at various stages of growth,
to explore the feasibility of using cells for the diagnosis of this aberration.
Such a study is in progress.
